Cargando…
Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest
OBJECTIVE: Cancer is one of the leading causes of mortality in both developed and developing nations. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is characterized by its ability to selectively trigger apoptosis in cancer cells. TRAIL-based interventions have led to the develo...
Autores principales: | Abdel Salam, Nagwa M, Abd-Rabou, Ahmed A., Sharada, Hayat M., EL Samea, Gehan G Abd, Abdalla, Mohga S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408384/ https://www.ncbi.nlm.nih.gov/pubmed/34048180 http://dx.doi.org/10.31557/APJCP.2021.22.5.1513 |
Ejemplares similares
-
Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2021) -
TRAIL combinations: The new ‘trail’ for cancer therapy (Review)
por: REFAAT, ALAA, et al.
Publicado: (2014) -
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
por: Abd-Rabou, Ahmed A., et al.
Publicado: (2023) -
Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2019) -
Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
por: Ehrhardt, H, et al.
Publicado: (2013)